Genetics and Molecular Biology of β-Lactam-Resistant Pneumococci

Penicillin-resistant pneumococci have been reported with increasing frequency in recent years. Isolates with high-level resistance are now found in many countries, and in some countries they constitute a substantial proportion of all isolates. A worrying development is the recent emergence of pneumo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Microbial drug resistance (Larchmont, N.Y.) N.Y.), 1995, Vol.1 (1), p.29-34
Hauptverfasser: Coffey, T J, Dowson, C G, Daniels, M, Spratt, B G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 34
container_issue 1
container_start_page 29
container_title Microbial drug resistance (Larchmont, N.Y.)
container_volume 1
creator Coffey, T J
Dowson, C G
Daniels, M
Spratt, B G
description Penicillin-resistant pneumococci have been reported with increasing frequency in recent years. Isolates with high-level resistance are now found in many countries, and in some countries they constitute a substantial proportion of all isolates. A worrying development is the recent emergence of pneumococci with high-level resistance to third-generation cephalosporins. Resistance to β-lactam antibiotics in pneumococci is due entirely to the development of altered forms of the high-molecular-weight penicillin-binding proteins (PBPs) that have decreased affinity for the antibiotics. High-level resistance to third-generation cephalosporins has occurred by the development of altered forms of PBP1a and 2x, whereas high-level penicillin resistance additionally requires alterations of PBP2b. Altered PBPs are encoded by mosaic genes that have emerged by recombinational events between the pbp genes of pneumococci and their homologs in closely related streptococcal species. Horizontal gene transfer, presumably mediated by genetic transformation, has also resulted in the dissemination of altered pbp genes, and possibly capsular biosynthetic genes, between different pneumococcal lineages to produce new resistant clones.
doi_str_mv 10.1089/mdr.1995.1.29
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77939091</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16831254</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-b52060aebcff86a7eaf26567937526470d116d7f5aa3a41cfe4026732131cacb3</originalsourceid><addsrcrecordid>eNqFkLFOwzAQQC0EKqUwMiJlYnPx2bEdjwVBQSoCIZgtx7FRUBIXOxn6W3wI30SqVqyd7nT39IaH0CWQOZBC3bRVnINSfA5zqo7QFBQDXOR5cTzuRAosqMpP0VlKX4QQDoJN0EQBF6yAKVosXef62qbMdFX2HBpnh8bE7LYOTfjcZMFnvz94ZWxvWvzmUp160_XZa-eGNthgbX2OTrxpkrvYzxn6eLh_v3vEq5fl091ihS0TrMclp0QQ40rrfSGMdMZTwYVUTHIqckkqAFFJz41hJgfrXU6okIwCA2tsyWboeuddx_A9uNTrtk7WNY3pXBiSlqNKEQUHQRAFA8rzEcQ70MaQUnRer2PdmrjRQPS2rR7b6m1bDZqqkb_ai4eyddU_vY85_tnuv72armtqV7rYH7D-ARvYhj8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16831254</pqid></control><display><type>article</type><title>Genetics and Molecular Biology of β-Lactam-Resistant Pneumococci</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>Coffey, T J ; Dowson, C G ; Daniels, M ; Spratt, B G</creator><creatorcontrib>Coffey, T J ; Dowson, C G ; Daniels, M ; Spratt, B G</creatorcontrib><description>Penicillin-resistant pneumococci have been reported with increasing frequency in recent years. Isolates with high-level resistance are now found in many countries, and in some countries they constitute a substantial proportion of all isolates. A worrying development is the recent emergence of pneumococci with high-level resistance to third-generation cephalosporins. Resistance to β-lactam antibiotics in pneumococci is due entirely to the development of altered forms of the high-molecular-weight penicillin-binding proteins (PBPs) that have decreased affinity for the antibiotics. High-level resistance to third-generation cephalosporins has occurred by the development of altered forms of PBP1a and 2x, whereas high-level penicillin resistance additionally requires alterations of PBP2b. Altered PBPs are encoded by mosaic genes that have emerged by recombinational events between the pbp genes of pneumococci and their homologs in closely related streptococcal species. Horizontal gene transfer, presumably mediated by genetic transformation, has also resulted in the dissemination of altered pbp genes, and possibly capsular biosynthetic genes, between different pneumococcal lineages to produce new resistant clones.</description><identifier>ISSN: 1076-6294</identifier><identifier>EISSN: 1931-8448</identifier><identifier>DOI: 10.1089/mdr.1995.1.29</identifier><identifier>PMID: 9156381</identifier><language>eng</language><publisher>United States</publisher><subject>Aminoacyltransferases ; Bacterial Proteins ; Carrier Proteins - genetics ; Genes, Bacterial ; Hexosyltransferases ; Muramoylpentapeptide Carboxypeptidase - genetics ; Penicillin Resistance - genetics ; Penicillin-Binding Proteins ; Peptidyl Transferases ; Recombination, Genetic ; Streptococcus pneumoniae ; Streptococcus pneumoniae - drug effects ; Streptococcus pneumoniae - genetics</subject><ispartof>Microbial drug resistance (Larchmont, N.Y.), 1995, Vol.1 (1), p.29-34</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-b52060aebcff86a7eaf26567937526470d116d7f5aa3a41cfe4026732131cacb3</citedby><cites>FETCH-LOGICAL-c363t-b52060aebcff86a7eaf26567937526470d116d7f5aa3a41cfe4026732131cacb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.liebertpub.com/doi/epdf/10.1089/mdr.1995.1.29$$EPDF$$P50$$Gmaryannliebert$$H</linktopdf><linktohtml>$$Uhttps://www.liebertpub.com/doi/full/10.1089/mdr.1995.1.29$$EHTML$$P50$$Gmaryannliebert$$H</linktohtml><link.rule.ids>314,776,780,3029,4010,21702,27900,27901,27902,55266,55278</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9156381$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Coffey, T J</creatorcontrib><creatorcontrib>Dowson, C G</creatorcontrib><creatorcontrib>Daniels, M</creatorcontrib><creatorcontrib>Spratt, B G</creatorcontrib><title>Genetics and Molecular Biology of β-Lactam-Resistant Pneumococci</title><title>Microbial drug resistance (Larchmont, N.Y.)</title><addtitle>Microb Drug Resist</addtitle><description>Penicillin-resistant pneumococci have been reported with increasing frequency in recent years. Isolates with high-level resistance are now found in many countries, and in some countries they constitute a substantial proportion of all isolates. A worrying development is the recent emergence of pneumococci with high-level resistance to third-generation cephalosporins. Resistance to β-lactam antibiotics in pneumococci is due entirely to the development of altered forms of the high-molecular-weight penicillin-binding proteins (PBPs) that have decreased affinity for the antibiotics. High-level resistance to third-generation cephalosporins has occurred by the development of altered forms of PBP1a and 2x, whereas high-level penicillin resistance additionally requires alterations of PBP2b. Altered PBPs are encoded by mosaic genes that have emerged by recombinational events between the pbp genes of pneumococci and their homologs in closely related streptococcal species. Horizontal gene transfer, presumably mediated by genetic transformation, has also resulted in the dissemination of altered pbp genes, and possibly capsular biosynthetic genes, between different pneumococcal lineages to produce new resistant clones.</description><subject>Aminoacyltransferases</subject><subject>Bacterial Proteins</subject><subject>Carrier Proteins - genetics</subject><subject>Genes, Bacterial</subject><subject>Hexosyltransferases</subject><subject>Muramoylpentapeptide Carboxypeptidase - genetics</subject><subject>Penicillin Resistance - genetics</subject><subject>Penicillin-Binding Proteins</subject><subject>Peptidyl Transferases</subject><subject>Recombination, Genetic</subject><subject>Streptococcus pneumoniae</subject><subject>Streptococcus pneumoniae - drug effects</subject><subject>Streptococcus pneumoniae - genetics</subject><issn>1076-6294</issn><issn>1931-8448</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkLFOwzAQQC0EKqUwMiJlYnPx2bEdjwVBQSoCIZgtx7FRUBIXOxn6W3wI30SqVqyd7nT39IaH0CWQOZBC3bRVnINSfA5zqo7QFBQDXOR5cTzuRAosqMpP0VlKX4QQDoJN0EQBF6yAKVosXef62qbMdFX2HBpnh8bE7LYOTfjcZMFnvz94ZWxvWvzmUp160_XZa-eGNthgbX2OTrxpkrvYzxn6eLh_v3vEq5fl091ihS0TrMclp0QQ40rrfSGMdMZTwYVUTHIqckkqAFFJz41hJgfrXU6okIwCA2tsyWboeuddx_A9uNTrtk7WNY3pXBiSlqNKEQUHQRAFA8rzEcQ70MaQUnRer2PdmrjRQPS2rR7b6m1bDZqqkb_ai4eyddU_vY85_tnuv72armtqV7rYH7D-ARvYhj8</recordid><startdate>1995</startdate><enddate>1995</enddate><creator>Coffey, T J</creator><creator>Dowson, C G</creator><creator>Daniels, M</creator><creator>Spratt, B G</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>1995</creationdate><title>Genetics and Molecular Biology of β-Lactam-Resistant Pneumococci</title><author>Coffey, T J ; Dowson, C G ; Daniels, M ; Spratt, B G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-b52060aebcff86a7eaf26567937526470d116d7f5aa3a41cfe4026732131cacb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Aminoacyltransferases</topic><topic>Bacterial Proteins</topic><topic>Carrier Proteins - genetics</topic><topic>Genes, Bacterial</topic><topic>Hexosyltransferases</topic><topic>Muramoylpentapeptide Carboxypeptidase - genetics</topic><topic>Penicillin Resistance - genetics</topic><topic>Penicillin-Binding Proteins</topic><topic>Peptidyl Transferases</topic><topic>Recombination, Genetic</topic><topic>Streptococcus pneumoniae</topic><topic>Streptococcus pneumoniae - drug effects</topic><topic>Streptococcus pneumoniae - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coffey, T J</creatorcontrib><creatorcontrib>Dowson, C G</creatorcontrib><creatorcontrib>Daniels, M</creatorcontrib><creatorcontrib>Spratt, B G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Microbial drug resistance (Larchmont, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coffey, T J</au><au>Dowson, C G</au><au>Daniels, M</au><au>Spratt, B G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetics and Molecular Biology of β-Lactam-Resistant Pneumococci</atitle><jtitle>Microbial drug resistance (Larchmont, N.Y.)</jtitle><addtitle>Microb Drug Resist</addtitle><date>1995</date><risdate>1995</risdate><volume>1</volume><issue>1</issue><spage>29</spage><epage>34</epage><pages>29-34</pages><issn>1076-6294</issn><eissn>1931-8448</eissn><abstract>Penicillin-resistant pneumococci have been reported with increasing frequency in recent years. Isolates with high-level resistance are now found in many countries, and in some countries they constitute a substantial proportion of all isolates. A worrying development is the recent emergence of pneumococci with high-level resistance to third-generation cephalosporins. Resistance to β-lactam antibiotics in pneumococci is due entirely to the development of altered forms of the high-molecular-weight penicillin-binding proteins (PBPs) that have decreased affinity for the antibiotics. High-level resistance to third-generation cephalosporins has occurred by the development of altered forms of PBP1a and 2x, whereas high-level penicillin resistance additionally requires alterations of PBP2b. Altered PBPs are encoded by mosaic genes that have emerged by recombinational events between the pbp genes of pneumococci and their homologs in closely related streptococcal species. Horizontal gene transfer, presumably mediated by genetic transformation, has also resulted in the dissemination of altered pbp genes, and possibly capsular biosynthetic genes, between different pneumococcal lineages to produce new resistant clones.</abstract><cop>United States</cop><pmid>9156381</pmid><doi>10.1089/mdr.1995.1.29</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1076-6294
ispartof Microbial drug resistance (Larchmont, N.Y.), 1995, Vol.1 (1), p.29-34
issn 1076-6294
1931-8448
language eng
recordid cdi_proquest_miscellaneous_77939091
source Mary Ann Liebert Online Subscription; MEDLINE
subjects Aminoacyltransferases
Bacterial Proteins
Carrier Proteins - genetics
Genes, Bacterial
Hexosyltransferases
Muramoylpentapeptide Carboxypeptidase - genetics
Penicillin Resistance - genetics
Penicillin-Binding Proteins
Peptidyl Transferases
Recombination, Genetic
Streptococcus pneumoniae
Streptococcus pneumoniae - drug effects
Streptococcus pneumoniae - genetics
title Genetics and Molecular Biology of β-Lactam-Resistant Pneumococci
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T22%3A24%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetics%20and%20Molecular%20Biology%20of%20%CE%B2-Lactam-Resistant%20Pneumococci&rft.jtitle=Microbial%20drug%20resistance%20(Larchmont,%20N.Y.)&rft.au=Coffey,%20T%20J&rft.date=1995&rft.volume=1&rft.issue=1&rft.spage=29&rft.epage=34&rft.pages=29-34&rft.issn=1076-6294&rft.eissn=1931-8448&rft_id=info:doi/10.1089/mdr.1995.1.29&rft_dat=%3Cproquest_cross%3E16831254%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16831254&rft_id=info:pmid/9156381&rfr_iscdi=true